LabReflex

• (00:00) - Intro

Workforce and AI in Laboratory Medicine

Summary The medical laboratory workforce faces a shortage compounded by retirements, requiring systemic changes in education. Guidance from CAP focuses on structuring case review to reduce interpretive errors. Furthermore, the integration of AI into lab medicine is moving toward validation stages, leveraging the standardized numeric data inherent in laboratory results.

Key takeaways

• The laboratory workforce shortage is not just about vacancies; it involves losing decades of experience through retirements, making it harder to backfill roles with equivalent expertise.
• MLS and MLT education must become a forefront field to address the shortage, requiring significant investment, such as proposals for establishing medical or MLS schools.
• Diagnostic error reduction guidance requires inter- and intra-divisional assessment of sign-outs to reinforce a structure for evaluation rather than seeking perfection.
• Laboratory medicine data—numeric measurements—is ideally suited for AI implementation because it is straightforward, unlike free-text physician notes.
• The future involves labs being involved in the validation and verification stage of AI development, ensuring models accurately reflect laboratory results.

Chapters 0:54 Workforce Crisis In Labs 6:06 Diagnostic Error Reduction Guidance 8:59 AI Solutions In Healthcare 14:20 Lab Medicine And AI Future 16:46 Final Thoughts On Topics

Mentioned CAP, AMA, Microsoft, ChatGPT, Anthropic.

• (00:00) - Intro

Field Notes 1: UAMS and MLS Training

The challenge of staffing Medical Laboratory Science positions, particularly in rural areas, and a scalable solution for recruitment.

Summary There is a significant shortage of Medical Laboratory Science staff, especially in rural settings, which creates severe staffing challenges for hospitals. The University of Arkansas for Medical Sciences developed an approach to address this by training personnel locally rather than requiring relocation, which proved effective in attracting and retaining talent.

Key takeaways

• Unfilled MLS positions are in the eight to ten percent range nationally.
• Unfilled rural MLS positions are significantly worse, at 15% or higher.
• Moving staff from metropolitan areas to rural communities for training is less effective than training locally.
• A successful model involves allowing trainees to stay in their community while completing training and continuing employment.
• The Arkansas program has achieved a 100 percent pass rate on board exams.
• This approach offers a scalable model for addressing healthcare staffing needs in rural areas.

DMT - Origins - Ep01 The history of the Diagnostic Management Team concept and why it took decades to fully implement.

Summary The evolution of diagnostic practice was driven by a need for clinicians to understand lab results, which faced significant resistance from the medical system's incentive structure. The speaker details how the shift from laboratory-focused thinking to patient-focused diagnosis required overcoming obstacles related to payment systems and professional ego. This process ultimately led to the development of the Diagnostic Management Team concept and its modern application with tools like AI.

Key takeaways

• Early efforts to implement diagnostic changes faced resistance because the existing payment system incentivized focusing on procedures rather than comprehensive patient outcomes.
• The movement toward a Diagnostic Management Team required shifting focus from laboratory-minded clinicians to patient-focused experts.
• Obstacles included finding faculty and residents willing to commit time to multidisciplinary learning, as many were focused only on routine tests.
• The concept evolved by realizing that the system needed an expert to provide answers, leading to the idea of a Diagnostic Center where experts could share knowledge across specialties.
• The evolution of the DMT was slow because it required overcoming systemic barriers related to payment structures and professional incentives over many years.

• (00:00) - Intro

The Medical Director Field Guide: How to Evaluate a Laboratory Before You Say Yes

Summary Evaluating a medical director role requires looking beyond compensation to assess the operational health, leadership, and cultural alignment of the laboratory. Prospective directors must ask critical questions about the lab's history, quality systems, staffing stability, and communication structure before committing. Understanding these factors is necessary to ensure the role provides genuine growth rather than just a paycheck.

Key takeaways

• Evaluate prospective medical directors using five domains: Leadership, Quality, Operations, Culture, and Alignment.
• Prioritize understanding what you are getting into before discussing compensation; money should be considered later in the evaluation process.
• Red flags include a lack of transparency regarding inspection findings, poor history of citations, recurring leadership conflicts, and high turnover rates.
• Assess operational stability by examining staffing ratios (manpower to testing) and whether there is an improvement mindset for addressing issues.
• Examine the relationship with clinicians; if clinicians view the lab as a core part of their workflow, it indicates better alignment.
• Ensure compensation matches responsibility, risk, and expected involvement, rather than focusing solely on the dollar amount.

Chapters 0:00 Evaluating Labs Before You Sign On 1:33 Lab Evaluation Rubrics For Directors 4:29 Why Medical Directorships Matter Most 12:49 Five Domains For Evaluating Roles 22:36 Red Flags Versus Green Flags

• (00:00) - Evaluating Labs Before You Sign On

Ebola Outbreak and Physician Shortages

Summary The episode discusses the challenges of managing an Ebola outbreak in the Democratic Republic of Congo, focusing on political instability, burial practices, and testing limitations. It then shifts to examining physician loan repayment models in the United States, specifically looking at how states like New Mexico are attempting to address physician shortages through financial incentives.

Key takeaways

• The recent Ebola outbreak involved a different strain, Bundy Bugio virus, which is less virulent but still poses risks.
• Restraining Ebola requires response operations that are disrupted by fragile infrastructure and local violence in affected regions.
• Burial practices were disrupted by local populations, creating further exposure events for the community.
• Contact tracing effectiveness was limited due to a lack of trust between local communities and outsiders.
• Physician loan repayment models, such as New Mexico's program offering $75,000 per year for four years, aim to attract physicians to areas with shortages.
• The physician supply shortage is projected to require nearly 86,000 additional physicians by 2036.
• Expanding medical school capacity takes several years, making it difficult to quickly address the need for new physicians.

Chapters 0:00 Welcome To LabReflex 1:04 Ebola Outbreak Details 10:25 Physician Loan Repayment Model

Mentioned Democratic Republic of Congo, Uganda, New Mexico, Texas Tech, CDC, AMS report.

Quotes > "I mean, this looks like every other disease you've ever heard about from Africa." > "The fact is that physician supply is one of these markets where if you have just too many physicians, then the salary for those physicians can really just drop off like a rock." > "We're paying for physicians to come, pay off their loans, and they'll probably stick around."

• (00:00) - Welcome To LabReflex

In this solo episode of LabReflex, Dr. Chris Zahner continues building the Lab Inspection Playbook with a practical look at common laboratory deficiencies. The point is not just to memorize a list of citations. The more useful question is why the same categories keep showing up across CAP, CLIA, COLA, Joint Commission, and other inspection frameworks.

The central idea: common deficiencies are where the lab’s documented system separates from its real operating system. They are predictable drift points. Competency becomes paperwork. Procedures fall behind practice. Proficiency testing becomes a score instead of a learning system. Maintenance logs get completed but not reviewed. Method comparisons are missed because the operation changed faster than the quality system. Director oversight becomes formal instead of functional.

1. Competency assessment

Competency assessment is one of the most consistent deficiency themes across inspection programs. The key issue is not simply whether a form was completed. It is whether the lab can show credible evidence that a person can actually perform the test system correctly, recognize when something is wrong, and respond appropriately. Training is not competency. A quiz alone is not competency. A signature is not competency.

Competency matters because it is one of the lab’s core safety systems. If a lab treats it as an annual paperwork ritual, it misses the point. A meaningful competency process should connect to real work, including routine testing, QC, maintenance, result reporting, and problem-solving.

Links:
CAP 2022 Top 10 Deficiencies: https://documents.cap.org/documents/Accreditation_2022_Top_10_Deficiencies.pdf
ASCLS Common Laboratory Deficiencies: https://ascls.org/common-laboratory-deficiencies-and-ways-to-avoid-them/

2. Procedure manuals and procedure reality

Procedure manuals are one of the clearest ways inspectors can see whether the lab’s written system matches actual bench practice. A procedure is not supposed to be a static document sitting in a folder. It should describe how the lab actually works. When the SOP says one thing, staff explain another thing, and the bench process works a third way, the lab no longer has a controlled process. It has institutional memory.

This is why inspection readiness is not binder readiness. It is reality alignment. The question is not just, “Does the procedure exist?” The question is, “Does the procedure match current practice, and can staff use it when something goes wrong?”

Links:
CMS 2024 CLIA Top Ten Deficiencies: https://www.cms.gov/regulations-and-guidance/legislation/clia/downloads/cliatopten.pdf
CAP Laboratory Quality Improvement Ideas From CAP Inspections: https://documents.cap.org/documents/CAP_Laboratory-Quality-Improvement-Ideas-From-CAP-Inspections_Apr-25-23.pdf

3. Proficiency testing

Proficiency testing is not just about passing. It is one of the lab’s external reality checks. PT asks whether the lab is getting the same answer others would get, whether the testing system is performing as expected, and whether failures or trends are being recognized and addressed.

The problem is that PT can become clerical: receive, test, submit, file, move on. But inspectors are often looking at the review process. Who reviewed it? Was anything unacceptable? Was there a trend? Was corrective action meaningful? PT is not just a grading event. It is a learning system.

Links:
CMS CLIA Proficiency Testing Brochure: https://www.cms.gov/files/document/clia-brochure-proficiency-testing-and-pt-referral-october-2024.pdf
CMS 2024 CLIA Top Ten Deficiencies: https://www.cms.gov/regulations-and-guidance/legislation/clia/downloads/cliatopten.pdf

4. Maintenance, function checks, temperatures, storage, and reagents

This is the boring operational category that reveals a lot about laboratory culture. Maintenance records, function checks, temperature logs, expired reagents, storage conditions, and equipment review are rarely conceptually difficult. They are difficult because they require reliable rhythm. The lab has to do the work, document the work, review the work, and respond when something is out of range.

A log without a response pathway is not a quality system. It is just a diary. The inspection question is not only, “Did you record the number?” It is, “What happens when the number is wrong?”

Links:
CAP Laboratory Quality Improvement Ideas From CAP Inspections: https://documents.cap.org/documents/CAP_Laboratory-Quality-Improvement-Ideas-From-CAP-Inspections_Apr-25-23.pdf
CMS 2024 CLIA Top Ten Deficiencies: https://www.cms.gov/regulations-and-guidance/legislation/clia/downloads/cliatopten.pdf

5. Method verification, AMR, and comparability

Method verification, analytical measurement range, and comparability are more technical, but they are common because labs change constantly. New instruments come in. Backup analyzers are added. Tests move between platforms. Point-of-care testing expands. Reagent lots change. Send-out tests come in-house. Each change may create a new obligation to verify, compare, document, or review.

The deeper problem is that labs often change faster than their quality systems. Every new method, instrument, backup process, or alternate pathway creates a new obligation to prove that results remain reliable.

Links:
ADLM Top Laboratory Deficiencies Across Accreditation Agencies: https://myadlm.org/cln/articles/2018/july/top-laboratory-deficiencies-across-accreditation-agencies
CAP Laboratory Quality Improvement Ideas From CAP Inspections: https://documents.cap.org/documents/CAP_Laboratory-Quality-Improvement-Ideas-From-CAP-Inspections_Apr-25-23.pdf

6. Personnel qualifications and director oversight

Personnel qualifications and director oversight connect common deficiencies to the larger issue of laboratory leadership. The lab director, technical supervisor, general supervisor, technical consultant, and other required roles are not just names on paper. They are part of the lab’s control structure. They help ensure people are qualified, PT is reviewed, procedures are appropriate, test systems are verified, and quality issues are addressed.

Many deficiencies look like documentation problems on the surface, but underneath they are ownership problems. Who owns competency? Who owns PT review? Who owns method comparability? Who owns corrective action follow-up? If nobody clearly owns the process, the proce...

This episode looks at new pressure points in lab medicine: payment reporting, LDT oversight, liquid biopsy expansion, supplier stability, and compliance risk.

PAMA reporting: CMS is collecting private-payer data for the Clinical Laboratory Fee Schedule, but Laboratory Economics reports CMS may not know exactly which labs qualify as “applicable laboratories.” That raises questions about data quality, enforcement, and future Medicare lab rates.

Enhancing CLIA Act of 2026: A new bill from Rep. Neal Dunn would keep LDT oversight centered in CLIA/CMS rather than FDA device regulation. It proposes a public LDT database, more transparency around validation and performance, third-party validity confirmation, centralized error reporting, and stronger CMS authority when LDT validity is questioned.

Guardant360 Liquid CDx: Guardant received FDA approval for an expanded liquid biopsy panel. The story highlights the growing role of blood-based genomic profiling in oncology, along with challenges around interpretation, limitations, and reimbursement.

Bio-Rad and Elliott: Elliott reportedly built a stake in Bio-Rad. For labs, this is a reminder that vendor strategy and financial pressure can affect reagents, QC materials, instruments, service, and validated workflows.

Key Takeaway

Labs are being asked to support payment policy, regulatory oversight, precision medicine, supply chains, and compliance systems. The big question: are the people designing these systems accounting for how labs actually work?

This week on LabReflex Pulse, Dr. Chris Zahner and Dr. Aakash Bhatia dive into a series of stories that all point toward a bigger shift happening inside laboratory medicine: diagnostics are becoming infrastructure.

From Nebraska rapidly validating an Andes virus PCR assay during a hantavirus scare… to Epic and Labcorp deepening diagnostic workflow integration… to AI pathology consolidation and real-time infectious disease surveillance dashboards — the organizations controlling diagnostic workflows may increasingly shape the future of healthcare itself.

This week’s topics:

Nebraska’s rapid Andes virus PCR response

Following a hantavirus outbreak aboard the MV Hondius cruise ship, the Nebraska Public Health Laboratory rapidly validated an Andes virus PCR assay before exposed passengers arrived in the United States. The story raises major questions about rare-pathogen preparedness and rapid assay deployment in the post-COVID era.

WIRED coverage:
https://www.wired.com/story/race-to-develop-andes-hantavirus-test/

CDC Health Alert:
https://www.cdc.gov/han/php/notices/han00528.html

WHO outbreak notice:
https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON600

Epic + Labcorp integration: interoperability or market positioning?

Labcorp announced expanded integration with Epic Aura, giving Epic users broader access to Labcorp’s testing menu and specialty diagnostics workflows. Chris and Aakash discuss whether EHR workflow design may increasingly influence diagnostic utilization — and whether hospital outreach laboratories should be paying closer attention.

Labcorp announcement:
https://ir.labcorp.com/news-releases/news-release-details/labcorp-and-epic-expand-collaboration-advance-diagnostic

ARUP launches infectious disease positivity dashboard

ARUP introduced a national infectious disease positivity trends dashboard using deidentified laboratory data to help identify emerging patterns and seasonal shifts. The episode explores whether large reference laboratories are quietly becoming real-time public health surveillance networks.

ARUP announcement:
https://www.aruplab.com/news/05-13-2026/arup-launches-national-infectious-disease-test-positivity-trends

Roche acquires PathAI

Roche announced plans to acquire digital pathology company PathAI in a major move signaling that AI pathology is transitioning from experimental technology to enterprise infrastructure.

Roche announcement:
https://www.roche.com/media/releases/med-cor-2026-05-07

Reuters coverage:
https://www.reuters.com/legal/litigation/switzerlands-roche-agrees-acquire-us-based-pathai-2026-05-07/

Quick Hit: Cepheid Xpert GI Panel

Cepheid received IVDR CE marking for its multiplex GI PCR panel, capable of detecting 11 gastrointestinal pathogens in approximately 75 minutes. The conversation touches on the continued expansion of rapid syndromic molecular testing and what it may mean for the future of microbiology workflows.

FDA summary:
https://www.accessdata.fda.gov/cdrh_docs/reviews/K251721.pdf

Cepheid announcement:
https://www.morningstar.com/news/pr-newswire/20260513la58308/cepheid-receives-ce-marking-under-ivdr-for-xpert-gi-panel

Subscribe to LabReflex!

For more conversations at the intersection of laboratory medicine, diagnostics, pathology, and healthcare strategy, subscribe wherever you get your podcasts.

Your Quality Plan Is Not Your Quality System

In this LabReflex deep dive, we break down a simple but important inspection-readiness idea:

A quality plan is what the lab says it does. A quality system is what actually happens when something goes wrong.

Many labs prepare for inspection by trying to show that failures never happen. But real quality is not about pretending the lab is perfect. It is about having a consistent, repeatable system for detecting problems, documenting them, reviewing them, correcting them, verifying the fix, and improving over time.

Key framework

Detect → Document → Review → Correct → Verify → Improve

A strong quality system makes follow-up obvious.

It helps the lab answer:

•  How did we know there was a problem? 
•  Where was it documented? 
•  Who reviewed it? 
•  What changed? 
•  Did the fix work? 
•  What improved because of it? 

Main example

We use critical value notification delays as an example.

A weak response is:

“Staff were reminded.”

A stronger response asks:

•  Why were the calls delayed? 
•  Was there a shift-specific pattern? 
•  Were contact numbers correct? 
•  Was the escalation process clear? 
•  Did the lab audit afterward to prove improvement? 

Big takeaway

The strongest labs are not the ones that claim they never have problems.

They are the ones that can show their quality system in action.

The goal is not perfection. The goal is control, learning, and consistent improvement.